Non-viral Peptide-based Intracellular Therapeutics Delivery Platform
A highly efficient platform for the delivery of protein therapeutics into cell via endosomal translocation & release.
Defining the future of intracellular therapeutics with TANA-Porter™ to control the cells innate healing power.
Tana-Porter™ can enhance the efficacy of currently available intracellularly active drugs i.e. chemotherapeutics thereby reducing dosage requirements and thus decrease toxicity and side effects profile.
Tana-porter™ delivers biologics such as proteins and nucleic acid to their intracellular target and realize their therapeutic potentials.